These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4557661)

  • 1. Psychiatric manifestations of levodopa.
    Yaryura-Tobias JA; Diamond B; Merlis S
    Can Psychiatr Assoc J; 1972; 17(2):Suppl 2:SS123. PubMed ID: 4557661
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of a decarboxylase inhibitor (Ro 4-4602) in combination with L-dopa on inhibited depressions].
    Matussek N; Benkert O; Schneider K; Otten H; Pohlmeier H
    Arzneimittelforschung; 1970 Jul; 20(7):934-5. PubMed ID: 4918921
    [No Abstract]   [Full Text] [Related]  

  • 3. Psychiatric aspects in Parkinsonism treated with L-dopa.
    Damãsio AR; Lobo-Antunes J; Macedo C
    J Neurol Neurosurg Psychiatry; 1971 Oct; 34(5):502-7. PubMed ID: 5127432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An exploration of the autonomic effects of phenothiazines.
    Acker CW
    Psychopharmacologia; 1965 Feb; 7(2):150-8. PubMed ID: 5319045
    [No Abstract]   [Full Text] [Related]  

  • 5. Parkinsonian syndromes. Treatment by association of L-dopa plus decarboxylase inhibitor.
    Gauthier G; Juge O; Birchler A
    Eur Neurol; 1974; 11(3):133-57. PubMed ID: 4839098
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results with the sustained-action neuroleptic fluspirilene on chronic schizophrenic patients undergoing occupational therapy].
    Gálfi B; Benson K; Grynaeus T
    Int Pharmacopsychiatry; 1973; 8(1):37-59. PubMed ID: 4595192
    [No Abstract]   [Full Text] [Related]  

  • 7. Response threshold to levodopa in psychiatric patients.
    Sathananthan G; Angrist BM; Gershon S
    Biol Psychiatry; 1973 Oct; 7(2):139-46. PubMed ID: 4584028
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic developments in chronic alcoholism. Treatment of dysthymic disturbances due to the deficiency syndrome in alcoholic subjects].
    Madeddu A
    Minerva Med; 1967 Feb; 58(12):400-6. PubMed ID: 5335499
    [No Abstract]   [Full Text] [Related]  

  • 9. [Oxyhemometric studies of patients with schizophrenia and reactive psychoses while treating them with neuroleptics].
    Timofeev NN; Kondrashenko VT; Nemtseva NIa
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(6):906-13. PubMed ID: 5723252
    [No Abstract]   [Full Text] [Related]  

  • 10. [The basic criteria for clinical evaluation of the effect of tranquilizers].
    Aleksandrovskiĭ IuA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(12):1873-82. PubMed ID: 5511527
    [No Abstract]   [Full Text] [Related]  

  • 11. [4 years of experience with dipotassium chlorazepate].
    Miletto G
    Ann Med Psychol (Paris); 1969 Mar; 1(3):468-73. PubMed ID: 5376740
    [No Abstract]   [Full Text] [Related]  

  • 12. [Situation of sultopride among present-day neuroleptics].
    Maurel H; Pujol B
    Encephale; 1975; 1(1):19-24. PubMed ID: 1093844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sulpyride in the treatment of chronic psychoses (our clinical experiences)].
    Uvod I
    God Zb Med Fak Skopje; 1972; 18():113-9. PubMed ID: 4576300
    [No Abstract]   [Full Text] [Related]  

  • 14. [Neuroleptics in the treatment of psychoses].
    Sedvall G
    Lakartidningen; 1972 Mar; 69():78-84. PubMed ID: 4664128
    [No Abstract]   [Full Text] [Related]  

  • 15. Double-blind study of tybamate in psychotic patients.
    Meshel E; Denber HC
    Dis Nerv Syst; 1967 May; 28(5):311-3. PubMed ID: 5338174
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxypertine in the treatment of schizophrenia.
    Alapin B; Golebiewska M
    Act Nerv Super (Praha); 1967 Nov; 9(4):436-9. PubMed ID: 4889080
    [No Abstract]   [Full Text] [Related]  

  • 17. Levodopa in Parkinson's disease: effect on pulmonary function.
    Nakano KK; Bass H; Tyler HR
    Arch Intern Med; 1972 Sep; 130(3):346-8. PubMed ID: 4560177
    [No Abstract]   [Full Text] [Related]  

  • 18. [Considerations on the therapeutic management of mixed psychoses and of depressive manifestations symptomatic of schizophrenia].
    Scala A
    Osp Psichiatr; 1967; 35(4):501-34. PubMed ID: 5607254
    [No Abstract]   [Full Text] [Related]  

  • 19. Lack of addiction from high doses of tybamate.
    Feldman HS; Mulinos MG
    J New Drugs; 1966; 6(6):354-60. PubMed ID: 5341417
    [No Abstract]   [Full Text] [Related]  

  • 20. [Psychopharmacological experiences with methophenazine with particular reference to Leonhard's classification of endogenous psychoses].
    Neumann J; Schulze HA
    Psychiatr Neurol Med Psychol (Leipz); 1966 Jan; 18(1):11-7. PubMed ID: 4862323
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.